Page last updated: 2024-11-03

rimantadine and Adenohypophyseal Diseases

rimantadine has been researched along with Adenohypophyseal Diseases in 1 studies

Rimantadine: An RNA synthesis inhibitor that is used as an antiviral agent in the prophylaxis and treatment of influenza.

Research Excerpts

ExcerptRelevanceReference
"Rimantadine treatment failed to restore growth or pituitary GH contents."1.33Hypothalamic growth hormone-releasing hormone (GHRH) deficiency: targeted ablation of GHRH neurons in mice using a viral ion channel transgene. ( Carmignac, DF; Houston, P; Le Tissier, PR; Lilley, S; Magoulas, C; Mathers, K; Ogden, D; Phelps, CJ; Robinson, IC; Sesay, AK, 2005)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Le Tissier, PR1
Carmignac, DF1
Lilley, S1
Sesay, AK1
Phelps, CJ1
Houston, P1
Mathers, K1
Magoulas, C1
Ogden, D1
Robinson, IC1

Other Studies

1 other study available for rimantadine and Adenohypophyseal Diseases

ArticleYear
Hypothalamic growth hormone-releasing hormone (GHRH) deficiency: targeted ablation of GHRH neurons in mice using a viral ion channel transgene.
    Molecular endocrinology (Baltimore, Md.), 2005, Volume: 19, Issue:5

    Topics: Animals; Antiviral Agents; Cytomegalovirus; Female; Growth Hormone-Releasing Hormone; Hypothalamus;

2005